Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Hormone-Refractory Prostate Cancer
NCT00201357Phase 2Completed
- Sponsor
- National Health Research Institutes
- Start
- Oct 2002
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in prostate cancer (PCa), sponsored by National Health Research Institutes. Started Oct 2002; status: completed.
02
Drugs
thalidomide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00201357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201357.